HOME >> BIOLOGY >> NEWS
Risk of ectopic pregnancies after IVF declines with age in women with tubal disease

Madrid, Spain: The first study to look at the risk of ectopic [1] pregnancies after IVF in a complete national ART register has unearthed a surprising result, a conference of international fertility experts heard today (Tuesday 1 July).

The researchers found that women face a slightly increased risk of ectopic pregnancies after IVF. More surprisingly, they found that whereas in the normal population the risk of an ectopic pregnancy increases with women's age, after IVF the risk decreases with age in women who have had diseased Fallopian tubes.

Elizabeth Asung, an honorary research fellow at Leeds University and The Bridge Centre in London, UK, told the annual conference of the European Society of Human Reproduction and Embryology that she had analysed data from the UK's Human Fertilization and Embryology Authority (HFEA) on 97,240 women, aged between 18-50 who underwent either straightforward IVF embryo transfer (IVF-ET) or embryo transfer after ICSI (ICSI-ET) between 1991 and 1999.

She and her colleagues found that after ICSI-ET the incidence of ectopic pregnancies was 1.3% a figure that places it firmly in the range of incidence in the normal population. However, after IVF-ET the numbers increased by roughly a half from between 1-2% in the normal population to 2.8%.

Ms Asung said: "The difference in the numbers of ectopic pregnancies after IVF-ET and ICSI-ET may be because with ICSI the women tend to have no or fewer abnormalities associated with infertility because it's the man's fertility that is at issue. Whereas with IVF there's a higher proportion of women with compounding problems such as tubal disease, which may be contributing to their infertility and which are risk factors for ectopic pregnancies."

The study found that when women's Fallopian tubes had been damaged by tubal disease, the numbers of ectopic pregnancies increased to 6.1% in women under the age of 25, 4.1% between 25 and 29, 3.9% between 30 a
'"/>

Contact: Emma Mason
wordmason@aol.com
44-0-1376-563090
European Society for Human Reproduction and Embryology
1-Jul-2003


Page: 1 2 3

Related biology news :

1. Marijuana use could cause tubal pregnancies
2. Study finds two-thirds of unplanned pregnancies in women using contraception
3. Component in plastic bottles found to cause abnormal pregnancies in mice
4. Researchers concerned over early egg retrieval after cancer treatment - doctors advised to monitor pregnancies as mice study reveals problems
5. Ringling Bros. announces four Asian elephant pregnancies at Center for Elephant Conservation
6. Common enzyme deficiency may jeopardize pregnancies
7. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
8. Why your knees and quads hurt more after running than walking: Youre only human
9. Fluid derived from aloe plant prolongs life after hemorrhagic shock in animal study
10. Researchers find that color perception is not innate, but acquired after birth
11. Reading hexametric rhyme supports cardiac synchronization, especially after a heart attack

Post Your Comments:
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... 2015-2019"  report to their offering. One ... technology. With continuous advances in technology, it is important ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:1/22/2015)... Jersey , 22 de enero de 2015  El Dr. ... hoy su llamada a nominaciones para 2015. Este prestigioso ... hecho, o tiene el potencial para hacer, contribuciones destacadas ... se aceptarán hasta el 15 de marzo de 2015 ...
(Date:1/22/2015)... 2015  Varian Medical Systems (NYSE: VAR ), world ... its commitment to sustainability with inclusion on a prestigious list ... ranked healthcare equipment company among the Corporate Knights Global 100 ... Forum at Davos, Switzerland . ...
(Date:1/22/2015)... 2015  Derma Sciences, Inc. (Nasdaq: DSCI ... wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic ... to the Premier, Inc. Regenerative Skin Grafting contract ... AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue to ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
Cached News: